Marianne Amalric Selected Research

Marianne Amalric Research Topics

Disease

23	Parkinson Disease (Parkinson's Disease) 11/2021 - 01/2002
9	Catalepsy 01/2015 - 07/2002
4	Parkinsonian Disorders (Parkinsonism) 10/2015 - 07/2002
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 07/2002
2	Cognitive Dysfunction 01/2019 - 08/2011
2	Dyskinesias (Dyskinesia) 02/2015 - 10/2014
1	Neurobehavioral Manifestations 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Movement Disorders (Movement Disorder) 01/2016
1	Hypokinesia (Bradykinesia) 01/2016
1	Brain Diseases (Brain Disorder) 04/2012

Drug/Important Bio-Agent (IBA)

9	Haloperidol (Haldol)FDA LinkGeneric 01/2015 - 07/2002
6	Dopamine (Intropin)FDA LinkGeneric 11/2021 - 02/2009
6	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 02/2015 - 07/2002
6	Levodopa (L Dopa)FDA LinkGeneric 02/2015 - 11/2006
5	Oxidopamine (6 Hydroxydopamine)IBA 01/2016 - 07/2002
4	Cholinergic Agents (Cholinergics)IBA 01/2021 - 10/2015
4	Glutamic Acid (Glutamate)FDA Link 02/2015 - 09/2003
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019 - 01/2016
2	Adenosine (Adenocard)FDA LinkGeneric 02/2012 - 09/2008
2	1-aminocyclopentane-1,3,4-tricarboxylic acidIBA 09/2008 - 06/2007
2	Metabotropic Glutamate 5 ReceptorIBA 12/2005 - 07/2002
1	telenzepineIBA 01/2016
1	Tropicamide FDA LinkGeneric 01/2016
1	Halorhodopsins (Halorhodopsin)IBA 01/2016
1	Muscarinic M4 ReceptorIBA 01/2016
1	Cholinergic Antagonists (Anticholinergics)IBA 10/2015
1	Bee Venoms (Bee Venom)IBA 01/2015
1	Cocaine (Cocaine HCl)IBA 10/2014
1	Potassium Channels (Potassium Channel)IBA 08/2014
1	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 02/2012
1	N-(3-chlorophenyl)picolinamideIBA 02/2012
1	LSP1 2111IBA 10/2009
1	metabotropic glutamate receptor 4IBA 10/2009
1	Dopamine Agents (Dopaminergic Agents)IBA 09/2008
1	Adenosine A2 Receptor AntagonistsIBA 09/2008
1	Piribedil (Trivastal)IBA 11/2006
1	Dopamine Agonists (Dopamine Agonist)IBA 11/2006
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2005
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 08/2004
1	Apomorphine FDA Link 08/2003
1	Antipsychotic Agents (Antipsychotics)IBA 08/2003
1	metabotropic glutamate receptor type 1IBA 07/2002
1	Therapeutic UsesIBA 01/2002

Therapy/Procedure

3	Therapeutics 02/2015 - 11/2006
1	Palliative Care (Palliative Therapy) 10/2009
1	Denervation 12/2005